Synonyms: K-777 | K777 | N-methyl-Pip-F-hF-VSφ | NMePip-Phe-hPhe-VSPh | S-001 | SLV213
Compound class:
Synthetic organic
Comment: K11777 (K777) is a clinical stage irreversible, dipeptide-vinyl sulfone cysteine protease inhibitor. It has reported activity at human cathepsin L and other CA clade cysteine proteases [2-5]. Original reports revealed anti-parasitic effects in vitro and in animal models [1-2,6].
SARS-CoV-2: Cathepsin L in human host cells is implicated in the processing (cleavage) of the viral spike protein of SARS coronaviruses, that is part of the viral entry process. K11777 blocks SARS-CoV-2 infection in vitro. Ligand Activity Visualisation ChartsThese are box plot that provide a unique visualisation, summarising all the activity data for a ligand taken from ChEMBL and GtoPdb across multiple targets and species. Click on a plot to see the median, interquartile range, low and high data points. A value of zero indicates that no data are available. A separate chart is created for each target, and where possible the algorithm tries to merge ChEMBL and GtoPdb targets by matching them on name and UniProt accession, for each available species. However, please note that inconsistency in naming of targets may lead to data for the same target being reported across multiple charts. ✖ |
|
Bioactivity Comments |
Evidence reported in 2015 showed that K777 blocked entry of pseudovirus forms of SARS-CoV and MERS-CoV into Vero E6 or HEK293 cells. This activity was attributed to its capacity to inhibit host cathepsin L. Subsequent to the pandemic spread of SARS-CoV-2, K777 was redeployed for this more recently evolved coronavirus. Studies showed that K777-mediated inhibition of human cathepsin L reduced SARS-CoV-2 infection of human and mouse cells without evident toxicity [3]. Cell types tested included Vero E6, HeLa/ACE2, Caco-2, and A549/ACE2 cells. K777 did not inhibit the two SARS-CoV-2 cysteine proteases, papain-like protease (PLpro) and 3CL-like/main protease (Mpro) in these studies. |
Selectivity at enzymes | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Key to terms and symbols | Click column headers to sort | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|